Multiple Sclerosis Brainstem Lesions: Clinical Syndromes and Symptom Spectrum

Brainstem involvement in multiple sclerosis (MS) is common (∼50% at autopsy) and produces distinctive syndromes due to dense packing of cranial nerve nuclei and long tracts.

Key Brainstem Syndromes in MS

SyndromeLocalizationClassic Features
INO (Internuclear Ophthalmoplegia)Medial longitudinal fasciculus (MLF) – pons/midbrainIpsilateral adduction deficit + contralateral abducting nystagmus. Convergence preserved. Bilateral in 30% MS.
One-and-a-half syndromeMLF + PPRF (or CN VI nucleus)Horizontal gaze palsy to one side + INO to the other. "Only eye moving is abducting eye on opposite side."
Trigeminal neuralgia (TN)CN V root entry zone (pons)Paroxysmal, electric-shock facial pain (V2/V3). MS-associated TN: younger, bilateral, often symptomatic (vs. vascular compression).
Facial palsy (CN VII)Facial nucleus/fascicle (pons)Lower motor neuron pattern (forehead spared in UMN). May be recurrent.
Dysarthria / DysphagiaCN IX, X, XII nuclei (medulla) + corticobulbar tractsScanning speech, nasal regurgitation, aspiration risk. Pseudobulbar affect (emotional lability).
Central vertigo / nystagmusVestibular nuclei, cerebellar connectionsDirection-changing, vertical, torsional nystagmus; not fatigueable; ± skew deviation.
Autonomic / RespiratoryMedullary centersNeurogenic bladder/bowel, orthostatic hypotension, central sleep apnea, periodic breathing.

Associated Long Tract Signs

  • Corticospinal: spasticity, hyperreflexia, Babinski, weakness.
  • Spinothalamic: contralateral pain/temp loss.
  • Dorsal column: ipsilateral vibration/proprioception loss.

Diagnostic & Monitoring

  • MRI brainstem: T2/FLAIR hyperintensities, gadolinium enhancement (active), T1 hypointensity (chronic "black holes").
  • VEP, BAER, SSEP for subclinical involvement.
  • EDSS heavily weighted by brainstem/cerebellar function.

Management

  • DMTs (high-efficacy early: anti-CD20, S1P modulators, natalizumab) reduce new lesions.
  • Symptomatic: baclofen/gabapentin (spasticity/neuropathic pain), carbamazepine/oxcarbazepine (TN), dalfampridine (walking), speech/swallow therapy, vestibular rehab.
  • Multidisciplinary: neurology, urology, PT/OT/SLP, neuropsychology, palliative care.

Brainstem MS is a marker of aggressive disease. Early high-efficacy DMT and symptomatic care preserve function.

Brain & Nervous System - Related Articles